School of Engineering
Showing 1-44 of 44 Results
-
Marc L. Salit
Adjunct Professor, Bioengineering
BioMarc is the Director of the Joint Initiative for Metrology in Biology, co-founded with Stanford University colleagues to create a new scientific institution devoted to biometrology -- the study of measurement science in biology.
His research is focused on innovation and development of measurement science, standards, methods, and tools for biology. These tools generate and sustain scientific advance by enabling sharing of reproducible data, results and materials; distribution of labor by supporting accurate, low-friction transactions; confidence in technologies permitting regulated applications; and access to quantitative measurement of previously inaccessible phenomena – all through systematic application of the principles of metrology.
Marc is an Adjunct Professor in the Stanford University Departments of Bioengineering and of Pathology, where he works closely with faculty colleagues and mentoring students and postdoctoral fellows. -
Krishna Shenoy
Hong Seh and Vivian W. M. Lim Professor and Professor, by courtesy, of Neurobiology, of Bioengineering and of Neurosurgery
Current Research and Scholarly InterestsWe conduct neuroscience, neuroengineering and translational research to better understand how the brain controls movement, and to design medical systems to assist people with paralysis. These are referred to as brain-machine interfaces (BMIs), brain-computer interfaces (BCIs) and intra-cortical neural prostheses. We conduct this research as part of our Neural Prosthetic Systems Lab (NPSL) and our Neural Prosthetics Translational Lab (NPTL), which I co-direct with Prof. Jaimie Henderson, M.D.
-
Patrick Slade
Postdoctoral Scholar, Bioengineering
Biohttps://www.pat-slade.com/
-
Christina Smolke
Adjunct Professor
BioProfessor Smolke's research program focuses on developing modular genetic platforms for programming information processing and control functions in living systems, resulting in transformative technologies for engineering, manipulating, and probing biological systems. She has pioneered the design and application of a broad class of RNA molecules, called RNA devices, that process and transmit user-specified input signals to targeted protein outputs, thereby linking molecular computation to gene expression. This technology has been extended to efficiently construct multi-input devices exhibiting various higher-order information processing functions, demonstrating combinatorial assembly of many information processing, transduction, and control devices from a smaller number of components. Her laboratory is applying these technologies to addressing key challenges in cellular therapeutics, targeted molecular therapies, and green biosynthesis strategies.
-
Hyongsok Tom Soh
Professor of Radiology (Early Detection), of Electrical Engineering and, by courtesy, of Chemical Engineering and of Bioengineering
BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.
-
Sandya Subramanian
Postdoctoral Scholar, Bioengineering
BioI'm a Stanford Data Science Postdoctoral Fellow and NINDS F32 Postdoctoral Fellow, and I work with Professor Todd Coleman in Bioengineering and Professor Sean Mackey in Pain Medicine. My research is on developing new technologies and methods to study the interactions between the brain and the gut, including the autonomic nervous system. Brain-gut interactions are poorly understood but involved in a number of disorders, such as functional gastrointestinal disorders, Parkinson’s disease, diabetes, migraine, and eating disorders. The goal of my research is to improve our ability to monitor and quantify these physiologic processes.
I completed my B.S. in Biomedical Engineering and Applied Mathematics & Statistics from Johns Hopkins University in 2015 and spent the next year as a Churchill Scholar at the University of Cambridge getting an M.Phil. in clinical neurosciences (all my research was computational). I then did my Ph.D. at MIT in the Harvard-MIT Health Sciences and Technology program, advised by Professor Emery Brown. During my PhD, I developed and tested models and methods to track unconscious pain under anesthesia in the operating room. I grew up in Grand Rapids, Michigan. -
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.
